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Abstract
Objectives: The overall objective of this practice inquiry project was to evaluate whether
providers in a primary care clinic in Louisville, KY were following the United States Preventive
Services Task Force (USPSTF) screening guidelines regarding colorectal cancer for patients
aged 50 -75. The study examined the types of screening recommended, and whether completion
of screening was documented in the medical record. Finally in this study, provider
recommendation for Colorectal Cancer Screening (CRC) was evaluated to determine if types of
screening recommended, and documentation varied based on the ethnicity of the patients.
Methods: This was a descriptive study using a retrospective chart review of patient medical
records (n= 200) in a primary care office located in Louisville, Kentucky. Charts were reviewed
and data collected for male and female patients ages 50-75, who were seen in the primary care
office between January 1, 2015 and December 31, 2015. Data was also collected and charts
examined on whether CRC screening was recommended, the type of screening that was
recommended, whether recommendation was based on ethnicity, and whether completion of
screening was documented.
Results: There was no statistically significant difference in gender by CRC screening
recommendation. According to the data, females were as likely to be recommended for CRC
screening as their male counterparts. There was no statistically significant relationship between
ethnicity and the recommendation of CRC screening. The data did reveal however, that the
providers overwhelmingly chose to recommend one type of screening (colonoscopy) over the
other types of screening, (e.g., Fecal Occult Blood, Fecal immunochemical test, Cologuard,
Flexible sigmoidoscopy). This might be due to the high predictive value of colonoscopy
compared to the other types of CRC screening processes. Also the data revealed that, while there
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was no statistically significant difference by age (p=.52), those recommended for CRC screening
were slightly older. (Mean=59.1) as compared to those not recommended 56.6 for screening.
This is older than what USPSTF recommends.
Conclusion: In this clinic, providers were as likely to recommend CRC screening for women as
for men. In addition, the CRC screening did not differ based on race or ethnicity.
Notwithstanding, it was apparent that younger patients were not screening for CRC at the same
rate compared to the older patients. There is need for provider improvement in recommendation
of CRC screening for the patients starting at age 50, in line with the USPSTF guidelines. This is
critical as new research has found colon cancer rates rising among individuals under 50.
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Introduction
According to the Centers for Disease Control and Prevention (CDC), cancer is one of the
leading causes of death in our society today. Mortality from colorectal cancer (CRC) is
declining, yet it remains the second-leading cause of cancer death and the third most common
cancer in men and women in the United States (CDC, 2015). The best news about colorectal
cancer is the knowledge that it can be prevented or cured if detected in the early stages. An
estimated 150,000 people are diagnosed annually, and 50,000 of them die from the disease
within 5-10 years of diagnosis (Freedman, Slattery, & Ballard-Barbash, 2009). The American
Cancer Society also estimates that 134,490 new cases of colorectal cancer will be diagnosed in
women and men, and that 49,190 women and men will die from this disease in 2016 (MacBride,
Pruthis, & Bevers, 2012). Screening of average-risk men and women aged 50 to 75 years is
recommended by the U.S Preventive Services Task Force (USPSTF), because early detection of
high-risk neoplasm, adenomas and cancers is associated with decreased CRC incidence and
mortality (Djenaba, King, Miller, & Richardson, 2012: National Cancer Institute, 2015).
Colorectal cancer can be prevented by screening, and early detection is crucial in its prevention
and management. The cost of treating this disease is enormous and is expected to increase by
78% by the year 2020 (American Cancer Society, 2011). Screening for colorectal cancer has
been shown to be a high impact cost-effective service (Maciosek, Coffield, & Flottemesch,
2010). To meet the mandates of Healthy People 2020 (2016), there is need to advocate for
screening of this preventable disease.
The purpose of this project was to determine if there were any differences in the
rate of provider adherence to recommendations for colorectal cancer screening based on
ethnicity.
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1. Determine if providers are adhering to USPSTF guidelines for recommending
colorectal cancer screening.
2. Determine which types of colorectal cancer screening are recommended.
3. Determine if there is documentation that colorectal cancer screening was done.
4. Compare provider recommendation to obtain colorectal cancer screening, the type of
screening recommended, and documentation that the screening was done by ethnicity.

Background/Literature Review
Kentucky ranks third highest in the nation for mortality from colorectal cancer (19.4 per
100,000) compared to the national average (16.3 per 100,000). The 2012 screening rate for
Kentucky was 65.9% which is slightly below the national rate of 67.3% (Kentucky Department
of Public Health 2012-2013). However, there has been an increase in the screening rates for
colorectal cancer in Kentucky from 35% in 1999 to 66% in 2012 (Knight et al., 2015). This is an
encouraging trend, however the same is not true among the African American population in
Kentucky. The incidence rate of colorectal cancer in the African American population is 74.4 per
100,000 men, 54.0 per 100,000 women, and the mortality rate is 30.1per 100,000 men and 22.7
per 100,000 women. The screening rate for the African American population in general is 63%.
(American Cancer Society, 2014-2016).
There is need to increase the screening rate amongst the African American community in
the state (Knight et al., 2015) because colorectal cancer rates in Kentucky are highest in black
men and women. In addition, the highest age-adjusted state mortality rates for black men are
more than 50% higher than those for white men. (American Cancer Society, 2014-2016).
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The U.S Preventive Services Task Force (USPSTF) developed a screening guideline for
colorectal cancer. The guideline was published in 2002, and was revised in 2008 and just
recently updated in 2016. The 2002 guideline recommended screening for colorectal cancer, for
average-risk adults aged 50 years and older. The revision by USPSTF in 2008 recommends
screening for colorectal cancer beginning at the age of 50 and continuing until the age of 75. The
testing or screening methodologies recommended are:
i)

flexible sigmoidoscopy every 5 years

ii)

Fecal occult blood testing (FOBT) every year with high sensitivity guaiac or FIT test.

iii)

Colonoscopy every 10 years.

iv)

Fecal immunochemical test (Fit) every year.
The new revision in 2016, recommends routine screening for CRC starting at age 50 and

continuing until age 75 years. It did not specify any testing modalities, rather it stressed the
importance of CRC screening, noting that screening for colorectal cancer is a substantially
underused preventative health strategy in the United States (Bobbins-Domingo, 2016). In
addition, the USPSTF recommended screening for individuals age 76 to 85 who had not been
screened previously, and without any comorbid conditions as long as the provider’s clinical
judgement is that it is in the patients’ best interest. (USPSTF, 2016). Other CRC screening
modalities that are routinely done are fecal immunochemical tests (FIT), and cologuard, double
contrast barium enema, multi-target stool DNA test, and CT colonography (Smith, Andrews,
Brooks, DeSantis, Fedewa, et. al., 2016)
Routine screening is a major factor in colorectal cancer prevention (American Cancer
Society, 2011-2013). Research has shown that African Americans aged 50 and above are less
likely to be screened than Caucasians of the same age. This has created disproportionate health

5

EVALUATION OF PROVIDER RECOMMENDATION OF COLORECTAL
disparities burden on this minority group (CDC, 2010; Holden, D.J et al. 2010). Lack of
physician recommendation is one of the frequently cited reasons patients do not screen for CRC
(Ahmed, Pelletier, Winter, & Albatineh, 2013; Knight, et. al., 2015).
The State of Kentucky has focused on increasing the prevention and early diagnosis of
colorectal cancer, by enacting legislation and supporting initiatives that will increase the number
of persons screened for colorectal cancer in the state. These measures are intended to increase
colorectal cancer screening in the state, thereby reducing the morbidity, mortality and the cost of
treating the disease in the commonwealth (KRS. 214.540, KRS. 214.542, and KRS.214.544)
Increasing the number of African Americans who are routinely screened for colorectal
cancer will reduce the mortality rate from colorectal cancer in this population. There are many
possible barriers for the low screening rates in the African American demographic. Barriers
include economic constraints, lack of proper/adequate insurance, education, sheer indifference,
and lack of provider recommendation (Knight, et. al., 2015). Other barriers to colorectal cancer
screening noted in the literature are lack of symptoms by the patient, potential embarrassment or
discomfort, and fear of finding cancer (American Cancer Society, 2011: Holden, Jonas, &
Porterfield, 2010). This project will focus and evaluate provider recommendations for CRC
screening in a primary care setting.
One of the ways a provider develops a health promotion plan for his/her patients is to
become knowledgeable about the common or current practice guidelines for preventative health
screenings. These guidelines when followed by the provider, encourage the patient to adopt a
health maintenance approach to their overall health outcome. CRC screening guidelines are the
preventative screening measures developed by the USPSTF and other organizations, which the
provider should offer to average at risk patients. The primary care provider is in a unique

6

EVALUATION OF PROVIDER RECOMMENDATION OF COLORECTAL
position to contribute to overall health of the patient by recommending the relevant screenings
when due. Considering the influence and impact a provider has on whether a patient screens for
colorectal cancer, there is need to examine if they are following the guidelines and
recommending the relevant screenings.
There is documented evidence that patients are likely to screen for colorectal cancer as
long as there is a recommendation from the provider. Provider recommendation for CRC
screening has been considered a strong predictor of screening amongst patients (Feldstein et al.,
2012, p. 198). However, data also exists that shows provider recommendation for CRC may be
influenced by the patients’ age and comorbidities, (Haggstrom, Klabunde, Smith, & Yuan,
2012), lack of agreement on the type of screening preferred by the patient and the one prescribed
by the provider, (Hawley et al., 2012).
Methods
Study Design
This study used a retrospective chart review of patient medical records to determine provider
adherence to the USPSTF screening guidelines for CRC, and whether there were differences
based on ethnicity. Charts were reviewed to determine if the providers were recommending CRC
screening for the appropriate age groups of all patients that received services in the clinic based
on the USPSTF guideline, and type of screening recommended. Records were also reviewed to
determine if CRC screening had been completed and documented. Rate, type of colorectal cancer
screening and documentation that CRC screening was done, was then compared by ethnicity.
Charts were reviewed by first looking at the health maintenance tab to see if the required
health screenings were documented as done. If there was no record of the screening in the health
maintenance tab, the referral and surgery tabs were reviewed to see if there was a referral for the
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screening documented in those tabs. Most of the time it took a complete review of the patients
office visit starting when they reached age 50 years, going through referrals and surgery notes to
find the documentation of colorectal cancer screening recommendation. Even when there was
documentation of CRC screening, it was difficult to determine if that was their second screening
or not, though if they were in their 50s it may be their first.

Study Permission.
Permission for this practice inquiry project were twofold. First, an application for the
study was made to the University of Kentucky Institutional Review Board (IRB), and permission
was granted by certificate No. 16-0478-P1G. Secondly, another permission for the study site
(clinic), and was granted by the Norton Healthcare Office of Research Administration (NHORA)
approval letter No. 16-N0134. Since this study was a retrospective chart review, the data that was
examined was stripped of any patient identifiable personal information. However, to preserve
confidentiality, the data was recorded in a crosswalk table and spreadsheet, and stored in the
Primary Investigators (PI) identity authenticated secure firewall protected folder at Norton
Healthcare. Since the study involved no more than minimal risk, the informed consent was
waived by the IRB. No patient identifiable information was extracted during data collection, and
none was in the data that was statistically analyzed.

Inclusion and Exclusion Criteria
Inclusion criteria were males and female patients, age 50 to 75, who were seen in the
clinic between January 1, 2015 and December 31, 2015. Exclusion criteria, were any patient not
within the age limit of 50-75 and not seen in the clinic between January 1, 2015 and December
31, 2015. A random sample of the charts from the EPIC medical record system of existing
8
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patients who met the inclusion criteria were selected for review using research randomizer. A
total of 200 charts of patients (100 males and 100 females) were chosen and reviewed, to
determine if screening for CRC was ordered, the type of screening recommended, and whether
the screening was documented as being completed.
Data Analysis
Data analysis was completed using the SPSS statistics (Version 23.0) from IBM Inc. Chicago IL.
Descriptive statistics were used to summarize patient demographic and clinical characteristics.
The Chi-square test of association was used to evaluate for significance of association between
two categorical variables as contained in the dataset, (e.g., age, sex, CRC recommendation and
documentation). The T-test was used to compare the mean age at which patients were
recommended for CRC screening. This study considered values of p < 0.05 to be statistically
significant for the analysis.
Results
Sample Characteristics
A total of 200 charts were reviewed for this project; 100 female and 100 male patients. The
average age of the patients was 58.7 years. Almost three-quarters of the patients (73%) were
Blacks/African Americans, 23% were Caucasian/white and less than 3% were Hispanic or other.
Few patients classified as Asians (1.5%)
Of the 200 charts that were reviewed, providers recommended CRC screening for 86% of
the patients. Providers documented that CRC screening had been completed for 84% of the
patients. There was no significant difference in CRC screening recommendation by age; the
patients who were recommended for screening were slightly older (Mean = 59) compared to
those who were not recommended for screening (Mean = 56; see Table 2). Although there was
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no significant difference in, the USPSTF recommends CRC screening begin at 50 years old
which is much younger than the average age of patients who were offered screening in this
study. In addition providers overwhelmingly recommended colonoscopy (100%) over other
screening modalities like FOBT, Flexible sigmoidoscopy, CT colonography and cologuard.
There was no statistically significant difference in whether the patients were recommended
screening by sex (p= .95), or ethnicity (p=.80; see table 2).
Discussion
This practice inquiry project evaluated provider practices in a Louisville primary care clinic. The
aim was to determine if the providers were recommending colorectal cancer screening for
average at risk patients in accordance with established guidelines. The project in particular
sought to determine if the providers were adhering to the USPSTF guideline, which types of
screening were recommended, if there was documentation that screening had been completed
and if there was a difference of the recommendation and documentation based on ethnicity. As
noted above, there was no statistically significant difference in CRC recommendation,
documentation of the recommendation and by ethnicity.
The most glaring practice discovered in this practice inquiry project was that providers did
not recommend for CRC screening until 9 years after the USPSTF recommends screening to
begin. The other practice noted was that providers mostly recommended colonoscopy for CRC
screening. Colonoscopy has always been considered the gold standard for screening of CRC,
because it can detect and remove precancerous polyps. It is used to confirm any positive test
results from the other screening modalities (American Cancer Society, 2011). This procedure
screens the entire large intestine and requires cleansing in advance (Mayo Clinic, 2008).
The other testing modalities endorsed by different guidelines each have some level of
empirical support for their effectiveness (Smith, Cokkinides, Brooks, Saslow, Shah, & Brawley,
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2011). They are easy to administer, inexpensive and convenient, but lack sensitivity for precancerous polyps. Colonoscopy on the other hand, notwithstanding the advantages, has been
shown to be time consuming for the patients, expensive and has a small but well documented
morbidity (USPSTF, 2008). Knowing what type of test the patient prefers will help in increasing
testing. Communication between the provider and the patient should be dynamic and
personalized to fit the patients’ socioeconomic status, age and race. (Walsh, Karliner, Burke,
Somkin, Pham & Pasick 2010). This makes it easier for the patient to grasp what the physician is
communicating to him/her. The physician should always discuss the different recommended
tests for CRC with all patients (Shokar, Carlson, & Weller, 2010). This will increase patient
confidence in the process and make them open to screen for CRC. Patients who are offered only
colonoscopy for initial CRC screening might not screen at all (Debourcy, Lichtenberger, Felton,
Butterfield, Ahnen, & Denberg, 2008).
In this study providers recommended CRC screening at the average age of 59 years, which
is older than the age recommended by the USPSTF. Even though this is comparable to the mean
age for screening reported in other studies (Imperiale, et al., 2002), this is not a good trend,
especially given the recent increase in incidence of colorectal cancer amongst patients younger
than 50 years of age. New research has found the incidence of colorectal cancer to be on the rise
among those under 50 years (Reinberg, 2016). There is need for the providers to make sure that
they recommend CRC screening for every eligible patient. The situation is made more dire with
the increase in the number of patients below 50 years old who have presented with colorectal
cancer.
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Limitations
There are some limitations to this study. The study was a retrospective chart review of 200
randomly selected medical records from 1800 records of eligible patients seen in the clinic
between January 1, 2015 and December 31, 2015. There may be need to increase the sample
size, though on the one hand the random sampling for this study decreased any potential bias, on
the other hand there were additional 1600 medical records from which the sample size could
have been increased. The second limitation is the time frame of the study. Review of charts
within a one year span may not be enough to make a definite conclusion about the provider
practices in the clinic, though it might point to a trend.
Another limitation to the study was the confusion created by data checkpoints in the charts.
There was a standard health maintenance tab in the charts. Information in the tab, most of the
time, did not correspond with information in the doctor’s note. When any health maintenance
module is completed by the patient, documentation of it in the appropriate place should be
automatic to reflect that it was completed or not. The Epic electronic health record is used across
the hospital system. Therefore, it should be easy to find any record of a procedure that was
performed within the healthcare system. This is not the case here, results of procedures
performed in the hospitals sometimes do not cross over to the outpatient clinic. This was the case
in some of the charts reviewed.
Implication for clinical practice
We are moving from a health maintenance paradigm to a health prevention scheme. Being
that CRC is rising amongst people younger than 50, there may be need to revise the
recommendations to lower the age threshold. Screening for colorectal cancer is one of the
preventative services recommended by the USPSTF. As mandated by the Patient Protection and
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Affordable Care Act (Green, Coronado, Devoe, & Allison, 2014), CRC screening is covered in
full at no cost to eligible patients. Providers should vigorously advocate for patients to screen for
this preventable disease. This can be done by developing a unique communication rapport with
the patients. There is also need to increase patient education with regard to the preventative
screenings, and monitoring of the providers to ensure they are recommending the relevant
screenings when due. This can be done by periodically auditing medical records of patients aged
50-75year, to determine if they are being offered any screening recommendations, as early as
possible depending on when they turned 50, or when they started receiving services at the clinic.
There is also the need to educate the providers on the screening recommendations for CRC
screening. The USPSTF guidelines recommend that screening for CRC start at age 50, for the
average at risk patient. Providers should adhere to this recommendation. This is especially
important given the recent increase in the incidence of colorectal cancer in patients younger than
50.
Recommendations for future study
Any future research on this topic in the same clinic or any other healthcare clinic should
involve a longitudinal study. This will allow for frequent chart audits to make sure that CRC
recommendations are made and also recorded as completed. Providers should also inform the
patients of all the different testing modalities available for CRC screening. This might increase
compliance. Having mentioned the limitations of the study, a process review of the
documentation module and a subsequent quality improvement plan in this clinic can be used to
drastically improve the above mentioned shortcomings.
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Conclusion
Colorectal cancer is a disease that can be prevented by routine screening. The Affordable
Care Act mandates that CRC screening be covered at no cost for average at risk patients aged 5075 years. The incidence of this preventable disease has started appearing in patients younger than
50 years. This makes it more imperative for the provider to recommend for the relevant
screenings and also teach patients about need to complete the screening and the risk of not doing
so. In this study, almost two thirds of the study population were African Americans. There was
no significant difference in CRC screening recommendation based on diversity. This being said,
the choice of actual screening or not depends on the patient. The provider can only impress on
the patient the need to screen for the disease, but cannot force them to do so. Educating the
patients on the need to do so, might increase compliance.
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Table 1
Demographic and clinical characteristics of the study sample (N =200)
n (%)
Age, Mean (SD)

58.72 (6.32)

Race
African American

146 (73%)

Asian

3 (1.5%)

Caucasian

46 (23%)

Hispanic

4 (2%)

Other

1 (0.5%)

Sex
Female

100 (50.0%)

Male

100 (50.0%)

CRC screening recommended
Yes

172 (86%)

No

28 (14%)

CRC Documented as completed
Yes

167 (84%)

No

33 (16%)
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Table 2
Comparison of CRC screening recommendation by ethnicity and sex
CRC screening recommended
Yes

No

n (%)

n (%)

Race

.80

African American

125 (72.7%)

21 (75.0%)

Other

47 (27.3%)

7 (25.0%)

Sex

.95

Male

87 (50.58)

13(50%)

Female

85 (49.42)

15 (50%)

59.08 (6.23)

56.57 (6.52)

Age, Mean (SD)

p

20

.052

